iA Global Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.72M Buy
12,135
+885
+8% +$221K 0.04% 247
2025
Q4
$2.71M Buy
11,250
+1,496
+15% +$383K 0.03% 239
2025
Q3
$2.67M Buy
9,754
+1,102
+13% +$301K 0.04% 229
2025
Q2
$2.23M Sell
8,652
-4,807
-36% -$1.15M 0.03% 235
2025
Q1
$3.01M Buy
13,459
+6,287
+88% +$1.47M 0.05% 200
2024
Q4
$1.64M Buy
7,172
+1,432
+25% +$345K 0.03% 258
2024
Q3
$1.4M Buy
5,740
+9
+0.2% +$2.01K 0.02% 302
2024
Q2
$1.1M Buy
5,731
+1,803
+46% +$366K 0.02% 293
2024
Q1
$778K Buy
+3,928
New +$720K 0.02% 332
2023
Q4
Sell
-1,794
Closed -$265K 503
2023
Q3
$265K Buy
+1,794
New +$324K 0.01% 393

Other funds holding RMD

iA Global Asset Management's RMD Position: Q1 2026 in Review

iA Global Asset Management increased its ResMed (RMD) stake by 7.9% in Q1 2026, buying an estimated $221K and bringing the position to 12,135 shares worth $2.72M. The position accounts for 0.04% of the portfolio, ranked #247.

iA Global Asset Management first reported a position in RMD in Q3 2023 and has held it in 10 quarters since. The position peaked at $3.01M in Q1 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • iA Global Asset Management held 12,135 shares of ResMed worth $2.72M as of Q1 2026.
  • iA Global Asset Management bought 885 ResMed shares in Q1 2026, an estimated $221K.
  • ResMed made up 0.04% of iA Global Asset Management's portfolio in Q1 2026, its #247 holding.
  • iA Global Asset Management first reported a position in ResMed in Q3 2023 and has held it in 10 quarters since.
  • iA Global Asset Management's ResMed position peaked at $3.01M in Q1 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.